We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.
- Authors
Rodríguez-Mañero, Moisés; Sarkozy, Andrea; Chierchia, Gian-Battista; Casado-Arroyo, Rubén; Ricciardi, Danilo; De Asmundis, Carlo; Brugada, Pedro
- Abstract
In patients with recurrent atrial fibrillation (AF), the hallmark of treatment has been the use of antiarrhythmic drugs (AADs). Goals of therapy include reduction in the frequency and duration of episodes of arrhythmia as well an emerging goal of reducing mortality and hospitalizations associated with AF. Safety and efficacy are important factors when choosing an antiarrhythmic drug for the treatment of AF, hence, if AAD are required for maintenance of sinus rhythm, their safety profi le, together with individual patient characteristics, should be of utmost concern. In the next paragraphs we would like to review some aspects (electrophysiologic effects, metabolism, side effects, current evidence and indication) of the most commonly used AAD for the management of patients with AF, following the Vaughan-Williams classification. However, this system is mainly based on ventricular activity, therefore, and due to its relatively atrial selective actions, some agents will not readily fit in the Vaughan Williams AAD classification. For that reason, in the final part of the manuscript, new promising agents will be reviewed separately.
- Subjects
ATRIAL fibrillation treatment; MYOCARDIAL depressants; ELECTROPHYSIOLOGY; ARRHYTHMIA; DRUG side effects; HOSPITAL care; BIOPHYSICS; HEART beat
- Publication
JAFIB: Journal of Atrial Fibrillation, 2013, Vol 5, Issue 5, p108
- ISSN
1941-6911
- Publication type
Article